Laura Marrone

856 total citations
24 papers, 605 citations indexed

About

Laura Marrone is a scholar working on Molecular Biology, Molecular Medicine and Infectious Diseases. According to data from OpenAlex, Laura Marrone has authored 24 papers receiving a total of 605 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 6 papers in Molecular Medicine and 4 papers in Infectious Diseases. Recurrent topics in Laura Marrone's work include Antibiotic Resistance in Bacteria (6 papers), Amino Acid Enzymes and Metabolism (4 papers) and Metabolism and Genetic Disorders (3 papers). Laura Marrone is often cited by papers focused on Antibiotic Resistance in Bacteria (6 papers), Amino Acid Enzymes and Metabolism (4 papers) and Metabolism and Genetic Disorders (3 papers). Laura Marrone collaborates with scholars based in Canada, Italy and United States. Laura Marrone's co-authors include Gary I. Dmitrienko, Carolyn Beebe Smith, Michael Brenner, John M. Hallenbeck, Kai U. Frerichs, Donald J. DeGracia, Thomas Dever, Gary S. Krause, Anthony J. Clarke and Thammaiah Viswanatha and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and PLoS ONE.

In The Last Decade

Laura Marrone

21 papers receiving 595 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Laura Marrone Canada 11 228 151 137 114 79 24 605
John D. Knafels United States 12 526 2.3× 60 0.4× 74 0.5× 9 0.1× 119 1.5× 16 940
Verena Kohler Sweden 14 413 1.8× 35 0.2× 58 0.4× 7 0.1× 62 0.8× 25 675
Anna‐Lena Gustavsson Sweden 15 366 1.6× 14 0.1× 102 0.7× 48 0.4× 87 1.1× 29 732
Cristina Patiño Spain 11 198 0.9× 13 0.1× 83 0.6× 22 0.2× 22 0.3× 14 677
Ryoko Tatsumi Japan 7 222 1.0× 38 0.3× 29 0.2× 16 0.1× 53 0.7× 12 558
Natalia Levina Russia 9 571 2.5× 24 0.2× 215 1.6× 19 0.2× 38 0.5× 10 735
José W. Rodríguez United States 14 151 0.7× 35 0.2× 23 0.2× 16 0.1× 46 0.6× 27 499
Tsung‐Han Chou United States 14 327 1.4× 128 0.8× 30 0.2× 3 0.0× 58 0.7× 32 656
Karin Melén Sweden 9 777 3.4× 47 0.3× 129 0.9× 5 0.0× 25 0.3× 9 1.0k
Balaji Santhanam United States 14 315 1.4× 11 0.1× 34 0.2× 24 0.2× 32 0.4× 20 514

Countries citing papers authored by Laura Marrone

Since Specialization
Citations

This map shows the geographic impact of Laura Marrone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Marrone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Marrone more than expected).

Fields of papers citing papers by Laura Marrone

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura Marrone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Marrone. The network helps show where Laura Marrone may publish in the future.

Co-authorship network of co-authors of Laura Marrone

This figure shows the co-authorship network connecting the top 25 collaborators of Laura Marrone. A scholar is included among the top collaborators of Laura Marrone based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura Marrone. Laura Marrone is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Marrone, Laura, Valeria Di Giacomo, Felix Hausch, et al.. (2025). Exploring the potential of selective FKBP51 inhibitors on melanoma: an investigation of their in vitro and in vivo effects. Cell Death Discovery. 11(1). 138–138.
2.
Giordano, Carolina, Laura Marrone, Simona Romano, et al.. (2024). The FKBP51s Splice Isoform Predicts Unfavorable Prognosis in Patients with Glioblastoma. Cancer Research Communications. 4(5). 1296–1306.
3.
Marrone, Laura, et al.. (2024). Metabolic vulnerability of cancer stem cells and their niche. Frontiers in Pharmacology. 15. 1375993–1375993. 2 indexed citations
4.
Marrone, Laura, Simona Romano, Alberto Morello, et al.. (2024). Tirofiban prevents the effects of SARS-CoV-2 spike protein on macrophage activation and endothelial cell death. Heliyon. 10(15). e35341–e35341.
5.
Tufano, Martina, Laura Marrone, Chiara DˈAmbrosio, et al.. (2023). FKBP51 plays an essential role in Akt ubiquitination that requires Hsp90 and PHLPP. Cell Death and Disease. 14(2). 116–116. 8 indexed citations
6.
Marrone, Laura, et al.. (2023). NLRP3, the inflammasome and COVID-19 infection. QJM. 116(7). 502–507. 17 indexed citations
7.
Marrone, Laura, M. D’Agostino, Carolina Giordano, et al.. (2023). Scaffold proteins of cancer signaling networks: The paradigm of FK506 binding protein 51 (FKBP51) supporting tumor intrinsic properties and immune escape. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 31(4). 423–436. 4 indexed citations
8.
LoBue, Vanessa, et al.. (2022). Behavioral avoidance of contagious and non-contagious adults. PLoS ONE. 17(8). e0272726–e0272726. 3 indexed citations
9.
Hinchliffe, Philip, Geneviève Labbé, Laura Marrone, et al.. (2018). Structural and Kinetic Studies of the Potent Inhibition of Metallo-β-lactamases by 6-Phosphonomethylpyridine-2-carboxylates. Biochemistry. 57(12). 1880–1892. 53 indexed citations
10.
Marrone, Laura, Ahmad Ghavami, Geneviève Labbé, et al.. (2015). Arginine-containing peptides as potent inhibitors of VIM-2 metallo-β-lactamase. Biochimica et Biophysica Acta (BBA) - General Subjects. 1850(11). 2228–2238. 6 indexed citations
11.
Ghavami, Ahmad, Geneviève Labbé, Jürgen Brem, et al.. (2015). Assay for drug discovery: Synthesis and testing of nitrocefin analogues for use as β-lactamase substrates. Analytical Biochemistry. 486. 75–77. 15 indexed citations
12.
Burk, Dan L., Ji‐Young Hwang, Ernest Y. Kwok, et al.. (2007). Structural Studies of the Final Enzyme in the α-Aminoadipate Pathway-Saccharopine Dehydrogenase from Saccharomyces cerevisiae. Journal of Molecular Biology. 373(3). 745–754. 17 indexed citations
13.
Viswanatha, Thammaiah, et al.. (2007). Assays for Β-Lactamase Activity and Inhibition. Methods in molecular medicine. 142. 239–260. 11 indexed citations
14.
Siemann, Stefan, et al.. (2002). N-Arylsulfonyl Hydrazones as Inhibitors of IMP-1 Metallo-β-Lactamase. Antimicrobial Agents and Chemotherapy. 46(8). 2450–2457. 91 indexed citations
15.
McAllister, Kelly A., Laura Marrone, & Anthony J. Clarke. (2000). The role of tryptophan residues in substrate binding to catalytic domains A and B of xylanase C from Fibrobacter succinogenes S85. Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology. 1480(1-2). 342–352. 12 indexed citations
16.
Marrone, Laura, Kelly A. McAllister, & Anthony J. Clarke. (2000). Characterization of function and activity of domains A, B and C of xylanase C from Fibrobacter succinogenes S85. Protein Engineering Design and Selection. 13(8). 593–601. 13 indexed citations
17.
Dick, Scott, et al.. (1999). Lysine: N6-Hydroxylase: Stability and Interaction with Ligands. Journal of Protein Chemistry. 18(8). 893–903. 9 indexed citations
18.
Marrone, Laura & Thammaiah Viswanatha. (1997). Effect of selective cysteine→alanine replacements on the catalytic functions of lysine:N6-hydroxylase. Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology. 1343(2). 263–277. 8 indexed citations
19.
Marrone, Laura, et al.. (1996). Lysine:N6-Hydroxylase: Cofactor Interactions. Bioorganic Chemistry. 24(3). 304–317. 6 indexed citations
20.
Marrone, Laura, et al.. (1996). Specificity of Lysine:N6-Hydroxylase: A Hypothesis for a Reactive Substrate Intermediate in the Catalytic Mechanism. Bioorganic Chemistry. 24(4). 401–416. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026